Navigation Links
CherryPharm First All-Natural Food to Improve Sleep
Date:6/9/2008

University of Rochester Medical Center study reports this juice has

beneficial effects on older adults with insomnia

NEW YORK, June 9 /PRNewswire/ -- CherryPharm -- a proprietary all-natural tart cherry juice blend based on the proven health benefits of cherries -- has been shown to improve aspects of sleep, according to a study by the University of Rochester Medical Center. This double-blind placebo controlled clinical trial tested the effectiveness of CherryPharm in older adults with insomnia. Results showed that for the first time a food had positive effects on measures of sleep with no harmful side effects. Tart cherries contain a variety of powerful antioxidants including sleep regulating melatonin and other naturally occurring phyto-nutrients. CherryPharm, Inc. has worked with Cornell University to develop a unique juice extraction and pouring technique designed to retain the healthy compounds found in whole tart cherries.

During the study, conducted by the Sleep & Neurophysiology Research Laboratory at the University of Rochester Medical Center, Rochester, NY, subjects were given a bottle of CherryPharm or placebo in the morning and another in the evening and were asked to track their sleep patterns in a diary. Compared to placebo, CherryPharm decreased the time it took to fall asleep (Sleep Latency) and decreased the time spent awake after falling asleep (Wake After Sleep Onset). With probability or "P" values of .047 and .011 respectively, these results are statistically significant. Modest trends, although not statistically significant, were also shown in favor of CherryPharm versus placebo with Sleep Efficiency and Total Sleep Time.

"This clinical trial suggests that CherryPharm, a natural juice, improves sleep in individuals with insomnia. Given the side effects of some prescription medications, it is encouraging to have a natural product as an alternative," states Dr. Wilfred Pigeon of the University of Rochester Medical Center and principal investigator on the study.

"CherryPharm has 50 whole tart cherries in every bottle and we're excited that our trials keep showing such positive results," adds CherryPharm President & Founder, John Davey. "Our all-natural juice is helping people lead healthier lifestyles."

Studies show that nutrients are best acquired through the consumption of whole foods. For individuals concerned about their sleep, all-natural CherryPharm made from whole tart cherries is now a safe, effective option with no harmful side effects. Previous studies on CherryPharm have shown that the juice lessens pain and speeds recovery from exercise and is higher in antioxidant ORAC units than the other leading brands of antioxidant juices, waters, and teas.

About CherryPharm, Inc.

CherryPharm, Inc. is a science-based company committed to pursuing and leveraging academic research on the natural health benefits of tart cherries into great tasting and clinically proven juices. The company's initial product, CherryPharm NATURAL HEALTH, is a proprietary all-natural cherry juice blend that is available for purchase in select stores and also online in 24-bottle cases for $48 or in 8-bottle packs for $20. Please visit http://www.cherrypharm.com for more information.


'/>"/>
SOURCE CherryPharm, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions
2. Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent
3. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
4. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
5. Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer
6. Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer
7. Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
8. Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors
9. PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM)
10. First Patient Enrolled in Global Phase III Study of Bevacizumab and Trastuzumab in Early Breast Cancer
11. Arpida Enrols First Patients in "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017 Research and Markets ... Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key ... to their offering. ... global pharmacogenomics market was valued at US$ 7,167.6 Mn in ... 2024, expanding at a CAGR of 5.6% from 2016 to ...
(Date:4/19/2017)... 19, 2017 Cardiology devices segment is anticipated to ... The Cardiology Devices segment is likely to create absolute ... in 2018 over 2017. By the end of 2027, Cardiology ... to US$ 700 Mn, expanding at a CAGR of 18.4% ... Asia Pacific reprocessed medical devices market ...
(Date:4/19/2017)... DALLAS , April 19, 2017 /PRNewswire/ ... that the first patients in Nashville ... in the Lower Esophageal Sphincter Stimulation for GERD (LESS ... device designed to provide long-term reflux control by restoring ... GERD affects nearly 65 million people in ...
Breaking Medicine Technology:
(Date:4/24/2017)... , ... April 24, 2017 , ... ... are expected to be diagnosed globally; approximately 25,000 of them will be malignant.(1) ... greater use of this type of healthcare model in the diagnosis and treatment ...
(Date:4/24/2017)... CA (PRWEB) , ... April 24, 2017 , ... As ... is worth a thousand words. The good news for single women is that she ... Attraction," which is available on April 25th. Joan's insight, personal experiences and sparkling sense ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... that over the last decade, student well-being has seriously declined. "When disenfranchised youth ... formal education, join the Islamic State to turn the historic multi-ethnic and multi-religious ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... Gallardo, DDS, PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium ... , The Oral Reconstruction Foundation will present its annual Global Symposium at the ...
(Date:4/24/2017)... ... 24, 2017 , ... A 2-in-1 bottleless water appliance provides ... 101 Water Texas, here are the ways in which this technology can benefit ... of pure, fresh, oxygenated water, with both cold and hot options. , Convenience ...
Breaking Medicine News(10 mins):